RSS

Recipharm

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

3 Nov 2017 14:27 News

Traditionally, excipient selection has been performed using trial-and-error based methodologies, which are time-consuming and expensive. In this article, Dr Amjad Alhalaweh, PhD, formulation scientist, Recipharm, discusses a new method, HTS more

30 Oct 2017 12:28 Opinion

In this roundtable, four industry leaders from Symbiosis Pharmaceutical Services, Recipharm, Sterling Pharma Solutions and Idifarma, reveal their thoughts on what the ‘mega trends’ are in the current pharma landscape. more

26 Oct 2017 06:00 , , , Opinion

Here, we reveal some of the news, developments and product innovations that have been released from the show floor of day 1 of this year’s CPhI Worldwide congress in Frankfurt more

24 Oct 2017 09:00 News

Contract development and manufacturing organisation (CDMO) — Recipharm and Kancera, a development company focused on cancer therapy, have entered into a contract for the development and manufacture of the pharmaceutical candidate KAND567. more

15 Sep 2017 12:04 News

Recipharm and Clinical Trial Consultants (CTC) have partnered to launch a new service that will help companies progress projects from early phase formulation development to clinical trial implementation with patients. more

13 Sep 2017 15:22 Technology

Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have collaborated to set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm’s development facility in Solna, Sweden. more

21 Jul 2017 11:24 News

Erik Haeffler, vice president of manufacturing services, Recipharm, examines the challenges and opportunities for a CDMO in the landscape of serialisation that contract partners must overcome. more

6 Jun 2017 14:50 Opinion

Contract development and manufacturing organisation (CDMO), Recipharm, has announced the strategic appointment in the UK and Ireland of Shabbir Mostafa. Mostafa will join the business management team as director. more

30 May 2017 12:04 News

Contract development and manufacturing organisation (CDMO), Recipharm, has delivered its first batch of serialised drug products to Saudi Arabia. This follows the introduction of new regulatory requirements in March this year. more

24 Apr 2017 12:11 News

Henrik Stenqvist has been appointed as the new executive vice president and chief financial officer of Recipharm. more

11 Apr 2017 11:15 News

Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long-term agreement with Sato Pharmaceuticals for the commercial manufacture and delivery of Emla Patch to Japanese market. more

27 Mar 2017 11:05 News

Contract development and manufacturing organisation, Recipharm, has announced that it has completed the acquisition of biopharma organisation Kemwell’s pharmaceutical business, located in Bengaluru India. more

27 Feb 2017 16:30 News

We spoke with four of the leading lights in the sector to find out what they think 2017 has in store for pharma more

17 Feb 2017 14:30 News

Recipharm has announced a €3.7 million investment to expand its lyophilisation capacity in Italy in response to growing customer demand more

25 Aug 2016 12:26

CDMO Recipharm has partnered with firms Marchesini, SEA Vision and TraceLink to develop new serialisation services. more

22 Jun 2016 09:49 Technology

Sophisticated solid dose formulations for fixed dose combinations – Jean-François Hilaire, Recipharm, explains how CDMOs can help optimise time-to-market more

9 May 2016 09:10 Opinion

Recipharm acquires a majority stake in Nitin Lifesciences (Nitin), an Indian sterile injectables CMO more

13 Apr 2016 13:54 News

Recipharm has acquired Mitim for £53.5m, adding scale and technology in injectable beta lactams to Recipharm’s portfolio, according to the company more

29 Feb 2016 16:54 News

Recipharm Venture Fund, Östersjöstiftelsen and Praktikerinvest have jointly invested kr28 million in Pharmanest. Recipharm’s part of the investment is kr8 million. more

9 Jul 2015 11:14 News